Real-Life Use of Anti-fibrotic Drugs in Patients With Idiopathic Pulmonary Fibrosis in Sweden
1 other identifier
observational
400
1 country
1
Brief Summary
The objective of the current research project is, by using high quality Swedish registry data, to evaluate use, tolerance and effect of anti-fibrotic drugs in IPF-patients. Secondary study objectives are to determine the clinical profile, determinants of treatment adherence, long-term safety and to describe the patient journey from the first sign of disease to end of treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2019
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2019
CompletedFirst Submitted
Initial submission to the registry
July 11, 2019
CompletedFirst Posted
Study publicly available on registry
July 15, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2021
CompletedJuly 15, 2019
July 1, 2019
2.9 years
July 11, 2019
July 11, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Anti-fibrotic drugs among the patients recorded in the Swedish IPF-registry
The use of anti-fibrostic drugs
2014-2020
Interventions
The real-Life use of anti-fibrotic drugs in patients with idiopathic pulmonary fibrosis in Sweden
Eligibility Criteria
Patients diagnosed with idiopathic pulmonary fibrosis included in the Swedish IPF-registry
You may qualify if:
- All subjects included in the Swedish IPF-registry
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Karolinska University Hospital
Stockholm, Sweden
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, Senior consultant
Study Record Dates
First Submitted
July 11, 2019
First Posted
July 15, 2019
Study Start
January 1, 2019
Primary Completion
December 1, 2021
Study Completion
December 1, 2021
Last Updated
July 15, 2019
Record last verified: 2019-07